Emergence agitation is common after nasal surgery under general anesthesia and may lead to serious consequences for the patient, including an increased risk of injury, pain, hemorrhage, and self-extubation. Despite decades of research, studies on the incidence, risk factors, and prevention of emergence agitation in adult patients are ongoing, and opinions differ on the different effects of inhalation and intravenous anesthesia.
P ostanestheic emergence agitation, also called emergence delirium, was first described by Eckenhoff et al 1 in 1961 as emergence excitement. In that clinical survey, the authors characterized emergence agitation as confusion, disorientation, crying, moaning, shouting, or screaming. The occurrence rate of emergence agitation was reported to range from 5% to 30%, depending on the distribution of patients and variables such as age, the presence of a urinary catheter or an endotracheal tube, or pain intensity. Although emergence agitation occurs infrequently, it is a clinically significant complication because patients can injure themselves or the medical staff. 2 The precise mechanism of emergence agitation has not yet been elucidated, but risk factors have been revealed through various retrospective and prospective studies. 3 The most common known risk factors are the presence of a urinary catheter or an endotracheal tube, postoperative pain, and younger age. The occurrence rate of emergence agitation is significantly higher in school-aged children, especially in those who receive volatile anesthesia with sevoflurane or desflurane. [3] [4] [5] [6] Despite decades of research, studies on the occurrence rate, risk factors, and prevention of emergence agitation in adult patients are still ongoing. In particular, opinions differ on the different effects of inhalation and intravenous anesthesia. [3] [4] [5] [6] In a prospective study of 1359 adult patients, 6 multivariate analysis showed that the method of anesthesia did not affect the occurrence of emergence agitation. Another prospective observational study of about 2000 adults 3 reported that the use of volatile anesthetic agents was associated with a higher occurrence rate of emergence agitation. In a 2015 retrospective study that investigated risk factors of emergence agitation after nasal surgery, 5 the use of sevoflurane was reported to increase the risk of emergence agitation by more than 2-fold. Therefore, we designed a prospective, single-blind, randomized study to compare the occurrence of emergence agitation in patients who underwent nasal surgery under volatile induction and maintenance of anesthesia (VIMA) or total intravenous anesthesia (TIVA).
Methods

Patients
This prospective, randomized, single-blind clinical trial evaluated patients undergoing open rhinoplasty, septoplasty, turbinoplasty, endoscopic sinus surgery, and functional endoscopic sinus surgery under general anesthesia. The trial protocol can be found in Supplement 1. This study was approved by the institutional review board of the Asan Medical Center, Seoul, Republic of Korea. Written informed consent was obtained from all participants before enrollment.
Patients were included if they were aged 20 to 79 years with an American Society of Anesthesiologists physical status of 1 to 3. Patients were excluded from the study if they had a diagnosis of mental illness according to the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) or if they had taken a neuroleptic or benzodiazepine for longer than 2 weeks within 1 month of surgery. Patients who were allergic to opioids or nonsteroidal anti-inflammatory drugs or who were diagnosed with asthma or nasal polyps were also excluded. Eligible patients were randomly assigned to receive TIVA or VIMA by an online randomization program (http:// www.randomization.com).
Study Design and Anesthesia
In the TIVA group, anesthesia was induced with propofol, 2 mg/ kg, before starting a target-controlled infusion with propofol and remifentanil hydrochloride using an Orchestra pump (Fresenius Kabi AG). The effect-site concentration was controlled at 2.0 to 2.5 μg/mL to maintain a Bispectral Index Score of 40 to 60 (range, 0-100). The remifentanil infusion was titrated to maintain the patient's blood pressure within 20% of the preoperative measurement. In the VIMA group, anesthesia was induced with inhaled sevoflurane and nitrous oxide and maintained with sevoflurane and 50% nitrous oxide in oxygen. After removal of the pharyngeal packing gauze at the end of surgery, administration of the anesthetic agents was immediately discontinued (time T0). After sufficient oral suctioning, the inhaled oxygen fraction was increased to 100% and thefreshgasflowrateto8Ltofacilitateemergence. Neuromuscular blocking was reversed with 0.4 mg of glycopyrrolate and 15 mg of pyridostigmine and confirmed using a train-of-four monitor. Patients received no simulation by investigators other than verbal stimulation performed every 30 seconds; patients were extubated once they regained consciousness and were able to obey an oral command (time T1).
Emergence is defined as the interval within 2 minutes after extubation. Sedation and agitation were assessed immediately after extubation using the following 2 scales: the Riker Sedation-Agitation Scale (RSAS) 7 and the Richmond AgitationSedation Scale (RASS). 8 The RASS and RSAS are tools for measuring the degree of agitation and delirium in stages. Although they are similar in content, they have slightly different scales (from fully sedative state to highly agitated state). The RASS is divided into 10 levels (range of scores, −5 to 4, with higher scores indicating greater agitation) and the RSAS into 7 levels (range of scores, 1-7, with higher scores indicating Meaning The occurrence of emergence agitation after nasal surgery under general anesthesia can be reduced by using total intravenous anesthesia rather than inhalation anesthesia.
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greater agitation). The agitation scores were assessed by independent anesthesiologists who were blinded to the anesthetic methods administered in this study. The patients recovered for 1 hour in the postanesthesia care unit. A welltrained nurse blinded to randomized study group evaluated pain intensity by using the Numeric Rating Scale (range, 0-10, with higher scores indicating worse pain) immediately after arrival, 30 minutes after arrival, and 60 minutes after arrival to the recovery room. Rescue analgesics, such as nonsteroidal anti-inflammatory drugs and opioids, were administered when the Numeric Rating Scale score exceeded 5.
Outcomes
The primary outcome of this study was the occurrence of emergence agitation. The definition of emergence agitation was based on an RASS score of at least 1 or an RSAS score of at least 5 immediately after extubation. The secondary outcomes were pain intensity and the need for rescue analgesics as well as the occurrence of immediate postoperative complications, including postoperative nausea and vomiting, itching or urticaria, desaturation, and shivering.
Sample Size and Statistical Analysis
Data were analyzed from October 26, 2016, through September 14, 2017. The PS power and sample size calculations (version 3.1.2; 2014) developed by the Department of Biostatistics, Vanderbilt University, Nashville, Tennessee, were used to calculate the sample size. 9 For the calculation of the sample size, a previous study by Yu et al 3 was used as reference. In their study, the anticipated occurrence rate of emergence agitation was 27.8% and 7.5% in the VIMA and TIVA groups, respectively, and a 10% screen failure rate was assumed. 3 Thus, we estimated that 120 patients (60 in each group) would be required to achieve a study power of 80% and detect a 75% lower risk of the primary end point with VIMA vs TIVA using a 2-sided χ 2 test at a significance level of .05. Although no formal interim analysis was planned, the difference in the occurrence rate of emergence agitation between the 2 groups was very high. Therefore, a sample size recalculation was performed based on pooled data from the first 74 patients that did not affect the type I error rate. Surprisingly, the occurrence rate of emergence agitation in the TIVA group was only 2.8%, instead of the initially expected 7.5%, and that in the TIVA group was 26.3%. Because of this lower occurrence rate observed in the TIVA group, the sample size was recalculated, raising the study power to 85%. Nevertheless, the recalculated total sample size was reduced (40 in each group, for a total of 80). Therefore, we stopped enrollment at 86 patients. All continuous variables are expressed as mean (SD), and categorical variables are expressed as frequencies and percentages. To compare perioperative data, an unpaired, 2-tailed t test was used for continuous variables and a χ 2 test was used for categorical variables. The risk difference and its 95% CI are calculated according to Altman et al. 10 All data manipulations and statistical analysis were performed using SPSS for Windows (version 21; IBM Corporation) and Stata software (version 13.1; StataCorp LP). Statistical significance was evaluated at the 2-sided α level of .05. The effect size and the corresponding 95% CIs are reported.
Results
A total of 86 patients were assessed for eligibility from (Figure 1 ). The baseline characteristics and intraoperative data of the study population are summarized in Table 1 and Table 2 . There were no significant differences between groups. The types of operation included endoscopic sinus surgery, endoscopic endonasal resection, septoplasty, turbinoplasty, and open rhinoplasty. In most cases, endonasal packing was performed for hemostasis. Sixty-three patients underwent bilateral endonasal packing (31 patients in the TIVA group and 32 patients in the VIMA group). We found no significant difference in the duration of anesthesia ( Table 2 ). The occurrence rate of emergence agitation in each group is shown in Figure 2 . Regardless of the method of anesthesia, 9 patients experienced emergence agitation (overall incidence, 11.2%) according to the RASS and 11 (overall incidence, 13.8%) according to the RSAS. Emergence agitation with an RASS score of at least 1 immediately after extubation occurred significantly less often in the TIVA group than in the VIMA group (1 of (Table 3) . However, 4 patients (10.0%) in the TIVA group and 8 (20.0%) in the VIMA group experienced severe cough immediately after extubation (Table 3) . During their stay in the postanesthesia care unit, only 1 patient (in the TIVA group) of the 80 experienced shivering (Table 3) . Postoperative pain intensity did not differ between the 2 groups, nor did the need for administration of rescue analgesics in the postanesthesia care unit (Table 3) .
Discussion
The main finding of the present study was that adult patients who underwent nasal surgery under general anesthesia were more likely to experience emergence agitation if they received VIMA vs TIVA. However, no difference in the occurrence rate of acute perioperative complications or pain intensity between the 2 groups was found. In children, the use of volatile anesthetic agents is a wellknown risk factor of emergence agitation. However, a paucity of research on emergence agitation is available in adults, and opinions are divided on whether the type of anesthetic agent affects the occurrence of emergence agitation. Several prospective observational studies of patients who underwent various surgical procedures revealed that the occurrence of emergence agitation did not increase with the use of volatile agents compared with propofol and that those volatile agents were not a risk factor of emergence agitation.
6,8 Conversely, Yu et al 3 observed that patients who received inhalational anesthesia showed a higher occurrence rate of emergence agitation than patients who received anesthesia with propofol; those authors demonstrated that the use of volatile agents was a risk factor of emergence agitation, which is consistent with the results of our research. Even in children, the mechanism underlying the association between emergence agitation and the use of inhaled anesthetic agents has not been fully elucidated. In the past, some investigators 3 argued that the occurrence rate of emergence agitation may be lower with TIVA because propofol and remifentanil can be eliminated from the body faster than inhaled anesthetic agents. However, although pediatric studies revealed that emergence from propofol was generally smoother and the occurrence rate of emergence agitation was lower compared with emergence from sevoflurane, the recovery times from propofol and sevoflurane were almost the same. 11 One possible explanation can be found in mouse experiments that showed nerves within the locus ceruleus, a site involved in adrenergic excitation, were especially stimulated by sevoflurane.
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Well-known risk factors for emergence agitation are pain, presence of an endotracheal tube and/or a urinary catheter, younger age, current smoking, and male sex. 3, 5, 13 In the present study, these risk factors were preadjusted to randomize the difference between the 2 groups. However, according to Tables 1 and 2 , the 2 groups did not have identical distribution. In the case of sex, a noticeable difference of 17.5% was reported. Male patients are generally known to show more emergence agitation than female patients. 3 In the present study, the occurrence rate of emergence agitation was lower in the TIVA group than in the VIMA group, despite the 17.5% more male patients included in the TIVA group. This difference reinforces the findings of the present study. Otorhinolaryngology surgery is also a known risk factor of emergence agitation, especially nasal surgery, possibly owing to the feeling of suffocation. 1,2 Two recent studies 2,5 evaluating adult patients who underwent nasal surgery showed the occurrence rates of emergence agitation were 22% and 50%. The first study 2 used the RASS to evaluate the occurrence of emergence agitation, whereas the second study 5 used the RSAS. In the present study, the overall occurrence rate of emergence agitation was 11.2% by the RASS and 13.8% by the RSAS. Although the occurrence rate of emergence agitation in the present study was similar to the overall occurrence rate of emergence agitation across patients who underwent different types of operations, this occurrence rate was relatively low for patients who underwent nasal surgery. This finding is probably due to the smoother emergence of patients in our study, as evidenced by the longer time between cessation of administration of anesthetic agents and extubation (11.75 and 11.18 minutes in our study vs 7.8 minutes in the study by Kim et al 2 ). The presence of an endotracheal tube is another well-known risk factor of emergence agitation. Because our patients were allowed to emerge slowly with no arousal other than verbal stimulation, they were able to eliminate a substantial amount of the anesthetic agents from the body. This process may explain the lower occurrence rate of emergence agitation in our study.
Moreover, another strength of this study is that we used 2 different variables to evaluate the occurrence of emergence agitation. Previous studies have used a variety of agitation scales, such as the RSAS, RASS, or the New Sheffield Sedation Scale; however, to our knowledge, none of these scales has been validated for use in the recovery room. Moreover, the occurrence rate of emergence agitation varies depending on which scale is used, although the RSAS and RASS have been found to have excellent interrater reliability. 6,14-17 Depending on which agitation assessment tool is used (RASS or RSAS), the occurrence rate of emergence agitation has been shown to vary from 20% to 60%. The present study used both assessment tools to examine these reported differences. The results showed a similar occurrence rate of emergence agitation between the evaluations performed using the RSAS and RASS. According to previous studies, 3, 5 the difference in the occurrence rate of emergence agitation between the TIVA and inhalation anesthesia was similar to that of our study. For example, Yu et al 3 showed that risk difference of postoperative emergence agitation between inhalation anesthesia and TIVA was 20.3%, although they used a different emergence agitation assessment tool from the present study and included all types of surgery. Another retrospective study for emergence agitation after nasal surgery 5 showed that risk differences in the occurrence rate of emergence agitation by RASS between the groups of inhalation anesthesia and TIVA was about 17.3%. Although exact validation was not performed for clinically important difference in emergence agitation, the result of the present randomized clinical trial revealed a higher risk difference in emergence agitation measured by the RASS between the VIMA and TIVA groups than a previous report 5 ( Figure 2 ).
Therefore, it was reasonable that the present results are clinically meaningful. Furthermore, the present study suggested that emergence agitation after nasal surgery under general anesthesia can be significantly reduced by using TIVA rather than VIMA.
As previously mentioned, the occurrence of emergence agitation after nasal surgery may increase owing to the feeling of suffocation. We hypothesized that emergence agitation would be more likely to occur in cases when both sides of the nose were congested owing to surgery or when both sides were packed. However, this hypothesis was not confirmed by the results of the study, which is consistent with previous studies that showed bilateral nasal packing was not a risk factor of emergence agitation. 5 Moreover, the need for rescue analgesics and immediate postoperative pain intensity was not influenced by the type of anesthetic agents used. This finding contradicts a previous report 18 that the use of remifentanil during thyroidectomy caused a higher intensity of immediate postoperative pain. One explanation for this discrepancy might be that nasal surgery is generally less painful than a thyroidectomy.
Strengths and Limitations
Despite some limitations, the findings of this study are important. Previous studies of emergence agitation in adult patients were mainly prospective observational or retrospective analysis. However, the present study was conducted as a prospective, randomized clinical trial and the anesthetic methods and emergence method were standardized across the study population. Moreover, patients in the present study only underwent a limited range of operation types, which further increases the objectivity of this analysis. Several limitations of our present study should be noted. Although the results suggest that the use of VIMA increases the occurrence rate of emergence agitation compared with TIVA, we cannot be sure that this outcome is due to the volatile agents alone. Considering as many factors that may affect the occurrence of emergence agitation as possible, we attempted the randomization and tried to anesthetize the 2 groups in an identical manner. However, differences may be found in areas that were not investigated in this study. For example, although the American Society of Anesthesiologists physical status and anesthesia time seem to differ between the 2 groups, they are not well-known risk factors. To clarify whether volatile agents directly affect the occurrence of emergence agitation, a more limited and specific experiment should be performed. Second, we did not assess the hypoactive type of delirium. In our study, we defined delirium as a RASS score of at least 1 or an RSAS score of at least 5, which means that only agitated people were diagnosed with emergence agitation. However, delirium can manifest as the hypoactive type, which can be evaluated using a sedation scale or the opposite part of the agitation scale. In this study, we concentrated on the agitation element of emergence agitation because agitation poses the greatest risk of harm to patients and staff.
Conclusions
In conclusion, the occurrence of emergence agitation after nasal surgery can be reduced using TIVA instead of VIMA. No difference was found in the rate of immediate perioperative complications. 
Study goals and objectives
The purpose of this study was to evaluate and compare the incidence of EA between group VIMA (volatile induction and maintenance anesthesia with sevoflurane) and group TIVA (total intravenous anesthesia with propofol and remifentanil)
Study Design
This prospective randomized, single-blinded study will be conducted at Asan Medical Center in Seoul, Republic of Korea. 
Methodology Intervention
Group TIVA will be induced by anesthesia with propofol 2 mg / kg and then maintained with propofol and remifentanil using Orchestra TCI pump. The propofol concentration will be maintained at a concentration (2.0-2.5 mcg / ml) by monitoring the bispectral index (with a bispectral index of 40-60). Remifentanil will be controlled to maintain blood pressure within 20% difference of the preoperative ward blood pressure. Subjects in the group will be maintained with sevoflurane and 50% N2O after anesthesia induction with sevoflurane. At the end of surgery, after removal of the pharyngeal packing gauze, the anesthetic (propofol and remifentanil, or Sevoflurane and N2O) will be terminated (T0). After sufficient oral suction, the fresh gas flow is set to 8 L / min and the FiO2 is set to 100% to recover from anesthesia. The muscle relaxant reversal agent (Robinul 0.4 mg + Pyridostigmine 15 mg) is also administered at this time. If the patient has enough muscle relaxation reversal using TOF, and If the anesthetics are thought to have been adequately r e m o v e d o r metabolized without any stimulation, verbal stimulation is performed at 30-second intervals. Extubation should be performed (T1) when recovery of consciousness is confirmed. If EA occurs, ensure that sufficient communication is available to ensure safety during transport to the recovery room.
Randomization and Blinding
Patients will be randomly assigned to one of two groups: the TIVA group or the VIMA group. Randomization will be performed a randomization tabl e u s i n g t h e website http://www.randomization.com. An independent outcome assessor will be assigned. The study patients will be blinded which group they are in.
Outcome Assessments
Primary outcome (emergence agitation scaling) assessment will be done immediately after extubation before transfer to post-anesthetic care unit by independent outcome assessor (anesthesiologist). During staying at post-anesthetic care unit (right after the arrival, 30 minute, 60minute), secondary outcome (pain, and other complications, such as shivering, nausea, or desaturation) will be evaluated by well-trained nurses.
Primary outcome is evaluated based on two scales (Riker sedation-agitated scale and RASS).
1) Riker sedation-agitated scale 2) RASS
Sample size calculation
Yu and Daihua et al. reported a prospective study of 27.8% incidence of emergence agitation after sevoflurane inhalation anesthesia and 7.5% incidence of TIVA after general anesthesia with TIVA. Based on this, we calculated the number of subjects using PS Power and Sample Size Calculations by setting the alpha value to 0.05 and the power to 0.8. The results showed that 60 subjects were needed in each group. A total of 120 people are needed.
Data Management and Statistical Analysis
After the examiner or the person designated by the examiner receives the approval of IRB, the subject's data will be collected. The collected data should be stored in the original locked place and the clinical data management should be performed in accordance with the data clean procedure.
To compare data between groups, the 2 test or Fisher's exact test will be used to assess categorical variables and the Student's t-test or Mann-Whitney U-test will be used to analyze continuous variable as appropriate. All data manipulations and statistical analyses will be performed using SPSS for Windows, version 21 (IBM Corp, Armonk, NY) and Stata software version 13.1 (StataCorp LP, College Station, TX). A two-tailed P-value of <0.05 will be considered to indicate a statistically significant difference.
Quality Assurance
This study will be conducted after approval by the IRB and will be subject to ongoing scrutiny.
Expected Outcomes of the Study
The incidence of emergence agitation in the group TIVA will be lower than that in the group VIMA.
Dissemination of Results and Publication Policy
After the results are drawn, they will be analyzed and published in the journal. We will then educate and treat patients as needed.
Duration of the Project
Planned enrollment duration for each subject: about 6 month Planned study duration: about I year We will start the study after the IRB approval and we will determine the duration of the study according to the patient's screening. Future schedule will be reported at the end of the study.
Problems Anticipated
There is no additional cost to use, and we will continue to work with people who will be in charge of research within the department.
Project Management
Jun-Young Jo: data interpretation, drafting the article, analysis and interpretation, and contributing to statistical analysis.
Kyeo-Woon Jung: data collection, and contributing to statistical analysis Seungwoo Ku: providing conception and design, and data collection Seong-Soo Choi: providing conception and design, drafting the article, data acquisition, data analysis and interpretation, and supervision
Ethics
All researchers received research ethics training. All study participants will be informed about the progress of the study and possible complications. This study will
